Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
AMPA receptor antibodies
ataxia
autoantibodies
autoimmune disease
cerebellum
children
GluD2
movement disorder
myoclonus
opsoclonus
opsoclonus-myoclonus syndrome
Purkinje cell
Purkinje cell surface antibody
Showing articles 750 to 800 of 809 << Previous Next >>

Regression of Pituitary Prolactinoma With Bromocriptine Administration
JAMA 245:1149-1150, Velentzas,C.,et al, 1981

Mental Disorders From Low-Dose Bromocriptine
NEJM 305:173, Pearson,K.D., 1981

Bromocriptine & Domperidone in the Treatment of Parkinson Disease
Neurol 31:662-667, Quinn,N.,et al, 1981

Lisuride in Parkinsonism
Neurol 31:371-376, Gopinathan,G.,et al, 1981

Treatment of Advanced Parkinson Disease With Pergolide
Neurol 31:675-682, Lieberman,A.,et al, 1981

Extrapyramidal Side-Effects Of Metoclopramide
Lancet 2:1254-1255, Kataria,M.,et al, 1981

Parkinsonism & Tardive Dyskinesia Associated With Long-Term Metoclopramide Therapy
NEJM 305:1417, Grimes,J.D., 1981

Akinetic Mutism from Hypothalamic Damage:Successful Treatment with Dopamine Agonists
Neurol 31:1435-1439, Ross,E.D.,et al, 1981

Delayed Clearance of Diazepam Due to Cimetidine
NEJM 302:1012-1014, Klotz,U.,et al, 1980

Humoral Immunity in Myasthenia Gravis:Effect of Steroids & Thymectomy
Neurol 30:554-557, Tindall,R.S.A., 1980

Alcohol Increases Bromocriptine's Side Effects
NEJM 302:806, Ayres,J.,et al, 1980

Motor Neuropathy Associated with Cimetidine
BMJ 281:974-975, Walls,T.J.,et al, 1980

Ultrastructural Localization of Ach Receptor at the Motor Endplate:MG & Other Neuromuscular Dis
Neurol 30:1203-1211, Tsujihata,M.,et al, 1980

Increased Hair Loss As A Side Effect of Bromocriptine Treatment
NEJM 303:1418, Blum,I.,et al, 1980

Reduction in Size of a Pituitary Tumor by Bromocriptine Therapy
NEJM 300:291-293, McGregor,A.M.,et al, 1979

The Prolactinoma Problem
NEJM 300:313-315, Reichlin,S., 1979

Bromocriptine in Parkinson Disease:Further Studies
Neurol 29:363-369, Lieberman,A.N.,et al, 1979

Meige Disease:Striatal Dopaminergic Preponderance
Neurol 29:1126-1130, Tolosa,E.S.,et al, 1979

Neonatal Myasthenia Gravis in the Infant of a Myasthenic Mother in Remission
Ann Neurol 6:72-75, Elias,S.B.,et al, 1979

Effect of Bromocriptine on Pituitary Tumor Size
BMJ 2:700-703, McGregor,A.M.,et al, 1979

Bromocriptine Fails To Stop Growth of Eosinophilic Adenoma In Acromegaly
NEJM 301:386, Salti,I.S., 1979

Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979

The Role of Bromocriptine in the Treatment of Parkinsonism
Neurol 29:1077-1083, Fahn,S.,et al, 1979

Serum Antibodies to Cytomegalovirus in Myasthenia Gravis:Effects of Thymectomy & Steroids
Neurol 28:273, Tindall,R.S.A.,et al, 1978

Function of Circulating Antibody to Acetylcholine Receptor in Myasthenia Gravis:Investigation by Plasma Exchange
Neurol 28:266, Newsom-Davis,J.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Comparison Between Lergotrile & Bromocriptine in Parkinsonism
Ann Neurol 3:319, Teychenne,P.F.,et al, 1978

Bromocriptine in Parkinsonism
Arch Neurol 35:503, Lees,A.J.,et al, 1978

Possible Psychiatric Reactions to Monosodium Glutamate
NEJM 299:902, Colman,A.D., 1978

Acetylcholine Receptor in Myasthenia Gravis:Increased Affinity for a-Bungarotoxin
Ann Neurol 4:250-252, Elias,S.B.,et al, 1978

Penicillamine-induced Myasthenia Gravis Associated with Antibodies to Acetylcholine Receptor
Neurol 28:847-849, Russell,A.S.,et al, 1978

Prolactin-Secreting Tumors & Hypogonadism in 22 Men
NEJM 299:847-852, Carter,J.N.,et al, 1978

Apomorphine Hydrochloride-Induced Improvement in Huntington's Chorea
Arch Neurol 35:27, Corsini,G.U.,et al, 1978

Cimetidine & Mental Confusion
NEJM 298:284, 1978. (Letter), McMillen,M.A.,et al, 1978

Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978

Lergotrile in the Treatment of Parkinsonism
Neurol 28:699, Klawans,H.L.,et al, 1978

Content of Acetylch Receptor & Antib Bound to Receptor in Myasth Gravis, Experi Autoimm Myasth Gravis, & Syndrome
Neurol 28:130, Lindstrom,J.M., 1978

Plasmapheresis & Immunosuppressive Drug Therapy in Myasthenia Gravis
NEJM 297:1134, Dau,P.C.,et al, 1977

Penicillamine-associated Myasthenia Gravis, Antiacetylcholine Receptor & Antistriational Antibodies
Am J Med 63:689, Masters,C.L.,et al, 1977

Prolactin-secreting Pituitary Tumors
Ann Neurol 2:148, Antunes,J.L.,et al, 1977

Drug Therapy of Tardive Dyskinesia
NEJM 296:257, Kobayashi,R.M., 1977

Anti-Acetylcholine Receptor Antibody in Neonatal Myasthenia Gravis
NEJM 296:55, Keesey,J.,et al, 1977

Anti-Acetylcholine Receptor IgG in Neonatal Masthenia Gravis
NEJM 297:169, Nakao,K., 1977

Myasthenia Gravis, Study of Humoral Immune Mechanisms by Passive Transfer to Mice
NEJM 296:125, Toyka,K.V.,et al, 1977

Successful Use of Bromocriptine in the treatment of a Patient with Chronic Portasystemic Encephalopathy
NEJM 296:793, Morgan,M.Y.,et al, 1977

Galactorrhea:A Study of 235 Cases, Including 48 with Pituitary Tumors
NEJM 296:589, Kleinberg,D.L.,et al, 1977

Opiate Receptors in the Brain
NEJM 296:266, Snyder,S.H., 1977

The Medical Letter
Bromocriptine, 19:1011977., , 1977

Cause of Weakness in Myasthenia Gravis
NEJM 294:722, Grob,D., 1976

Treatment & Prognosis of Hemiballismus
NEJM 295:1348, Klawans,H.L.,et al, 1976



Showing articles 750 to 800 of 809 << Previous Next >>